Page 1 of Clinical Trials for Tumor Regression, 236 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Optimum Timing for Surgery After Pre-operative Radiotherapy
Last Updated: December 18, 2009
Condition(s): Adenocarcinoma of the Rectum
2
Completed
Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes
Last Updated: August 10, 2011
Condition(s): Anti-p53 TCR-Gene
3
Recruiting
Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer
Last Updated: May 10, 2012
Condition(s): Metastatic Melanoma; Metastatic Renal Cell Cancer; Metastatic Cancer
4
Terminated
Gene Therapy Using Anti-Her-2 Cells to Treat Metastatic Cancer
Last Updated: January 5, 2012
Condition(s): Metastatic Cancer
5
Terminated
Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced Melanoma
Last Updated: March 14, 2012
Condition(s): Metastatic Melanoma; Skin Cancer
6
Terminated
Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced Melanoma
Last Updated: March 13, 2012
Condition(s): Metastatic Melanoma; Skin Cancer
7
Terminated
Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
Last Updated: March 14, 2012
Condition(s): Metastatic Melanoma; Metastatic Renal Cancer
8
Completed
Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma
Last Updated: August 12, 2011
Condition(s): Melanoma; Skin Cancer
9
Active, not recruiting
Ultrasound Elastography in Patients With Rectal Cancer
Last Updated: May 7, 2012
Condition(s): Rectal Cancer
10
Completed
Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
Last Updated: September 22, 2011
Condition(s): Breast Cancer
11
Recruiting
Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients
Last Updated: April 7, 2011
Condition(s): Melanoma
12
Recruiting
Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
Last Updated: April 10, 2012
Condition(s): Metastatic Melanoma; Skin Cancer
13
Completed
Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene
Last Updated: February 6, 2009
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
14
Recruiting
Endoscopic Treatment of Inoperable Colorectal Cancer With the EndoVe System
Last Updated: September 26, 2011
Condition(s): Colorectal Cancer
15
Completed
Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma
Last Updated: March 14, 2012
Condition(s): Melanoma (Skin)
16
Terminated
Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma
Last Updated: March 28, 2012
Condition(s): Melanoma (Skin)
17
Completed
Vaccine Therapy With or Without Interleukin-2 After Chemotherapy and an Autologous White Blood Cell Infusion in Treating Patients With Metastatic Melanoma
Last Updated: February 6, 2009
Condition(s): Melanoma (Skin)
18
Enrolling by invitation
Pilot Study of PDL to Treat BCC and SCCIS
Last Updated: November 22, 2010
Condition(s): Basal Cell Carcinoma; Squamous Cell Carcinoma in Situ
19
Terminated
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer
Last Updated: March 21, 2012
Condition(s): Kidney Cancer; Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol Specific
20
Completed
Lymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Last Updated: February 6, 2009
Condition(s): Melanoma (Skin)

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Tumor+Regression

Page 1 of Clinical Trials for Tumor Regression, 236 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About